RxDoctor Payments DataLook up a doctor →

Amar Patel, MD

Interventional Cardiology · Marietta, GANPI 1750402491

Payments from drug & device makers

$1,756,962in general payments, 2019–2025

Across 960 payments — averaging $1830.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corvista Health, Inc.$654K
  • Boston Scientific$606K
  • Abbott$450K
  • Medical Device Business Services, Inc.$19K
  • Medtronic$17K
  • Edwards Lifesciences$6K
  • plus $5K from 30 others
$1,575in research payments, 2019–2025

Across 1 payment — averaging $1575.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$2K

What the payments were for

  • Consulting fees$1,0001%
  • Speaking & faculty fees$23,81333%
  • Grants$890%
  • Travel & lodging$18,68326%
  • Food & beverage$28,21739%
  • Education$8401%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Corvista Health, Inc.3$653,766
Boston Scientific277$606,283
Abbott307$449,775
Medical Device Business Services, Inc.11$19,224
Medtronic(2 entities)136$17,276
Edwards Lifesciences137$5,681
Pfizer10$1,020
Shockwave Medical, Inc11$819
W. L. Gore & Associates, Inc.8$558
Abiomed9$485
Cvrx, Inc.2$344
Philips North America LLC3$197
Livanova USA, Inc.3$186
Siemens Medical Solutions USA, Inc.2$152
Heartflow, Inc.1$150
Novartis6$136
Steris Corporation1$125
E.r. Squibb & Sons, L.L.C.7$123
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)3$105
Stryker1$79
Johnson & Johnson(2 entities)3$57
Cardiva Medical, Inc.2$45
Amgen2$43
Boehringer Ingelheim2$32
Actelion Pharmaceuticals US, Inc.1$32
Recor Medical Inc1$32
Catalyst Pharmaceuticals, Inc.1$31
Sanofi-aventis U.S. LLC2$31
Astellas Pharma US Inc1$26
AbbVie1$24
Penumbra, Inc.1$23
Cardiac Dimensions, Inc.1$23
Lundbeck LLC1$20
La Jolla Pharmaceutical Company1$20
Baxter Healthcare1$19
United Orthopedics LLC1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,756,962 in reported general payments places this provider in the 95th percentile of 218 interventional cardiology providers in Georgia.

See all interventional cardiology providers in Georgia →

Medicare billing

Part B allowed, 2024
$152,239
Medicare patients
396
Services billed
613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate34$315

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Marietta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →